Stocks · US
AZN
XNYS
AstraZeneca PLC
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E109.30x
P/B17.94x
P/S10.09x
EPS$1.43
ROE16.42%
ROA3.45%
Dividend yield1.46%
EV/EBITDA48.41x
Debt/Equity1.40
Free cash flow$2.3B
Returns and 52-week range
1W-3.41%
1M-2.51%
3M-16.20%
6M-21.01%
1Y-7.04%
YTD-13.39%
52W high$212.71
52W low$153.41
From 52W high-25.43%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 써모 피셔 사이언티픽 | $250.2B | 35.92 | 4.75 | +6.97% |
| 암젠 | $217.9B | 24.92 | 18.64 | -7.92% |
| 노바티스(ADR) | $267.9B | 39.64 | 3.70 | -12.00% |
| 길리어드 사이언스 | $179.3B | — | 15.16 | -4.48% |
| 유나이티드헬스 그룹 | $339.8B | 24.06 | 3.45 | -5.24% |
| 애보트 래브러토리스 | $173.2B | 31.93 | 3.39 | -9.39% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.